Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen: Evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes

Journal of Infectious Diseases

Volumn 180, Issue 5, 1999, Pages 1466-1476

  Gao, Shou Jiang ^a,d   Zhang, Yan Jin ^a   Deng, Jian Hong ^a   Rabkin, Charles S ^b   Flore, Ornella ^c   Jenson, Hal B ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE MAPPING; GENETIC POLYMORPHISM; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANTIGENS, VIRAL; CELL LINE; CHROMOSOME MAPPING; DNA, VIRAL; GENOTYPE; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SARCOMA, KAPOSI;

EID: 0032702945     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315098     Document Type: Article

References (37)

1. 1. Zong JC, Metroka C, Reitz MS, Nicholas J, Hayward GS. Strain variability among Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by it single common isolate. J Virol 1997;71: 2505-11.
2. 2. Di Alberti L, Ngui SL, Porter SR, et al. Presence of human herpesvirus 8 variants in the oral tissues of human immunodeficiency virus infected persons. J Infect Dis 1997;175:703-7.
3. 3. Foreman KE, Alkan S, Krueger AE, Panella JR, Swinnen LJ, Nickoloff BJ. Geographically distinct HHV-8 DNA sequences in Saudi Arabian iatrogenic Kaposi's sarcoma lesions. Am J Pathol 1998;153:1001-4.
4. 4. Luppi M, Barozzi P, Marasca R, Ferrari MG, Torelli G. Human herpesvirus 8 strain variability in clinical conditions other than Kaposi's sarcoma. J Virol 1997;71:8082-3.
5. 5. Boralevi F, Masquelier B, Denayrolles M, et al. Study of human herpesvirus 8 (HHV-8) variants from Kaposi's sarcoma in France: is HHV-8 subtype A responsible for more aggressive tumors? J Infect Dis 1998;178:1546-7.
6. 6. Caterino-de-Araujo A. Human herpesvirus 8 group B and C variants circulating in São Paulo, Brazil. J Infect Dis 1998;177:1136-7.
7. 7. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus-like agent associated with Kaposi's sarcoma. J Virol 1996;70: 549-58.
8. 8. Zimber U, Adldinger HK, Lenoir GM, et al. Geographical prevalence of two Epstein-Barr virus types. Virology 1986;154:56-66.
9. 9. Ernberg I, Kallin B, Dillner J, et al. Lymphoblastoid cell lines and Burkitt-lymphoma -derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. Int J Cancer 1986;38:729-37.
10. 10. Sample J, Young L, Martin B, et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990;64: 4084-92.
11. 11. Gratama JW, Oosterveer MA, Weimar W, et al. Detection of multiple "Ebnotypes" in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol 1994;75:85-94.
12. 12. Rainbow L, Platt GM, Simpson GR, et al. The 222-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997;71:5915-21.
13. 13. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335: 233-41.
14. 14. Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2: 925-8.
15. 15. Kedes DH, Operskalski E, Busche M, Flood J, Kohn R, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma associated herpesvirus): distribution of infection in KS risk groups for sexual transmission. Nat Med 1996;2:918-24.
16. 16. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two AIDS-related lymphoma cell lines containing Kaposi's sarcoma associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-14.
17. 17. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996;88:2648-54.
18. 18. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996;2:342-6.
19. 19. Bauer HM, Ting Y, Greer CE, et al. Genital papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:2809-10.
20. 20. Russo JJ, Bohenzky RA, Chien M, et al. Nucleotide sequence of Kaposi's sarcoma associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996;93:14862-7.
21. 21. Miller G, Heston L, Grogan E, et al. Selective switch between latency and lytic replication of Kaposi's sarcoma associated herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol 1997; 71:314-24.
22. 22. Staskus KA, Zhong WD, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997;71:715-9.
23. 23. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol 1997;71:7963-8.
24. 24. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:570-1.
25. 25. Diaz-Cano SJ, Wolfe HJ. Clonality in Kaposi's sarcoma. N Engl J Med 1997;337:571.
26. 26. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997;50: 664-8.
27. 27. Gill PS, Tsai YC, Rao AP, et al. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA 1998;95:8257-61.
28. 28. Rabkin CS, Bedi G, Musaba E, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res 1995;1:257-60.
29. 29. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
30. 30. Yao QY, Rowe M, Marin B, Young LS, Rickinson AB. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. J Gen Virol 1991;72:1579-90.
31. 31. Apolloni A, Sculley TB. Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes. Virology 1994;202:978-81.
32. 32. Sculley TB, Appolloni A, Hurren L, Moss DJ, Cooper DA. Coinfection with A-and B-type Epstein-Barr virus in human immunodeficiency virus positive subjects. J Infect Dis 1990;162:643-8.
33. 33. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-8.
34. 34. Nicholas J, Zong JC, Alcendor DJ, et al. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/ HHV8. J Int Cancer lnst Monogr 1998;23:79-88.
35. 35. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus 8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 1999; 96:4546-51.
36. 36. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999;284:641-4.
37. 37. Sarid R, Wiczorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol 1999;73:1438-46.